The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: A systematic review with meta-analysis
den Brok EJ, Svensson CH, Panagiotou M, et al.
Diabetes Obes Metab. Pub. online 19 Mar 2024.
Leggi
Breaking news
HLA Class II (DR, DQ, DP) genes were separately associated with the progression from seroconversion to onset of type 1 diabetes among participants in two diabetes prevention trials (DPT-1 and TN07)
Zhao LP, Papadopoulos GK, Skyler JS, et al.
Diabetes Care. 2024;dc231947.
Leggi
REZDIFFRA (resmetirom): FDA approves first treatment for patients with liver scarring due to fatty liver disease
14/03/2024
Leggi
FDA clears first over-the-counter continuous glucose monitor: Dexcom Stelo Glucose Biosensor System
05/03/2024
Leggi
Wegovy (semaglutide) injection: FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight
08/03/2024
Leggi
Management of outpatients with diabetes at high risk of hypoglycemia
Thomas CC, Chopra K, Davis AM
JAMA. Pub. online 14 Mar 2024.
Leggi
Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
Zilstorff DB, Richter MM, Hannibal J, et al.
BMC Endocr Disord. 2024;24(1):38.
Leggi
Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: Evidence from the Henan Rural Cohort
Yang T, Wu C, Li Y, et al.
NMCD. Pub. online 13 Mar 2024.
Leggi
An exploratory analysis of the cost-effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model
Shao H, Shi L, Fonseca V, et al.
Diabet Med. 2024;e15303.
Leggi
The difference between Cystatin C- and Creatinine-based estimated glomerular filtration rate and risk of diabetic microvascular complications among adults with diabetes: A population-based cohort study
He D, Gao B, Wang J, et al.
Diabetes Care. 2024;dc232364.
Leggi